ID   AADAT_RAT               Reviewed;         425 AA.
AC   Q64602;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 154.
DE   RecName: Full=Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial {ECO:0000305};
DE            Short=KAT/AadAT;
DE   AltName: Full=2-aminoadipate aminotransferase;
DE   AltName: Full=2-aminoadipate transaminase;
DE            EC=2.6.1.39 {ECO:0000269|PubMed:7493966};
DE   AltName: Full=Alpha-aminoadipate aminotransferase;
DE            Short=AadAT;
DE   AltName: Full=Glycine transaminase AADAT {ECO:0000250|UniProtKB:Q8N5Z0};
DE            EC=2.6.1.4 {ECO:0000250|UniProtKB:Q8N5Z0};
DE   AltName: Full=Kynurenine aminotransferase II;
DE   AltName: Full=Kynurenine--glyoxylate transaminase AADAT {ECO:0000250|UniProtKB:Q8N5Z0};
DE            EC=2.6.1.63 {ECO:0000269|PubMed:7493966};
DE   AltName: Full=Kynurenine--oxoglutarate aminotransferase II;
DE   AltName: Full=Kynurenine--oxoglutarate transaminase 2;
DE            EC=2.6.1.7 {ECO:0000269|PubMed:7493966};
DE   AltName: Full=Kynurenine--oxoglutarate transaminase II;
DE   AltName: Full=Methionine--glyoxylate transaminase AADAT {ECO:0000250|UniProtKB:Q8N5Z0};
DE            EC=2.6.1.73 {ECO:0000250|UniProtKB:Q8N5Z0};
DE   Flags: Precursor;
GN   Name=Aadat {ECO:0000312|RGD:2948}; Synonyms=Kat2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND HOMODIMERIZATION.
RC   TISSUE=Kidney;
RX   PubMed=7493966; DOI=10.1074/jbc.270.49.29330;
RA   Buchli R., Alberati-Giani D., Malherbe P., Koehler C., Broger C.,
RA   Cesura A.M.;
RT   "Cloning and functional expression of a soluble form of kynurenine/alpha-
RT   aminoadipate aminotransferase from rat kidney.";
RL   J. Biol. Chem. 270:29330-29335(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transaminase with broad substrate specificity. Has
CC       transaminase activity towards aminoadipate, kynurenine, methionine and
CC       glutamate. Shows activity also towards tryptophan, aspartate and
CC       hydroxykynurenine. Accepts a variety of oxo-acids as amino-group
CC       acceptors, with a preference for 2-oxoglutarate, 2-oxocaproic acid,
CC       phenylpyruvate and alpha-oxo-gamma-methiol butyric acid. Can also use
CC       glyoxylate as amino-group acceptor (in vitro).
CC       {ECO:0000269|PubMed:7493966}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-kynurenine = H2O + kynurenate + L-
CC         glutamate; Xref=Rhea:RHEA:65560, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:29985, ChEBI:CHEBI:57959,
CC         ChEBI:CHEBI:58454; EC=2.6.1.7; Evidence={ECO:0000269|PubMed:7493966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65561;
CC         Evidence={ECO:0000305|PubMed:7493966};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-2-aminoadipate = 2-oxoadipate + L-
CC         glutamate; Xref=Rhea:RHEA:12601, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:57499, ChEBI:CHEBI:58672; EC=2.6.1.39;
CC         Evidence={ECO:0000269|PubMed:7493966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12602;
CC         Evidence={ECO:0000305|PubMed:7493966};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + glycine = glyoxylate + L-glutamate;
CC         Xref=Rhea:RHEA:14089, ChEBI:CHEBI:16810, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:36655, ChEBI:CHEBI:57305; EC=2.6.1.4;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-kynurenine = glycine + H2O + kynurenate;
CC         Xref=Rhea:RHEA:65896, ChEBI:CHEBI:15377, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454; EC=2.6.1.63;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65897;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-hydroxy-L-kynurenine + glyoxylate = glycine + H2O +
CC         xanthurenate; Xref=Rhea:RHEA:65900, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:36655, ChEBI:CHEBI:57305, ChEBI:CHEBI:58125,
CC         ChEBI:CHEBI:71201; EC=2.6.1.63;
CC         Evidence={ECO:0000269|PubMed:7493966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65901;
CC         Evidence={ECO:0000305|PubMed:7493966};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxohexanoate + L-kynurenine = H2O + kynurenate + L-2-
CC         aminohexanoate; Xref=Rhea:RHEA:66060, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:35177, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454,
CC         ChEBI:CHEBI:58455; Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66061;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-phenylpyruvate + L-kynurenine = H2O + kynurenate + L-
CC         phenylalanine; Xref=Rhea:RHEA:66092, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:18005, ChEBI:CHEBI:57959, ChEBI:CHEBI:58095,
CC         ChEBI:CHEBI:58454; Evidence={ECO:0000269|PubMed:7493966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66093;
CC         Evidence={ECO:0000305|PubMed:7493966};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-methylsulfanyl-2-oxobutanoate + L-kynurenine = H2O +
CC         kynurenate + L-methionine; Xref=Rhea:RHEA:69096, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16723, ChEBI:CHEBI:57844, ChEBI:CHEBI:57959,
CC         ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69097;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxo-3-sulfanylpropanoate + L-kynurenine = H2O + kynurenate +
CC         L-cysteine; Xref=Rhea:RHEA:69104, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:35235, ChEBI:CHEBI:57678, ChEBI:CHEBI:57959,
CC         ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69105;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=indole-3-pyruvate + L-kynurenine = H2O + kynurenate + L-
CC         tryptophan; Xref=Rhea:RHEA:66052, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17640, ChEBI:CHEBI:57912, ChEBI:CHEBI:57959,
CC         ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66053;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxopentanoate + L-kynurenine = H2O + kynurenate + L-2-
CC         aminopentanoate; Xref=Rhea:RHEA:66076, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:28644, ChEBI:CHEBI:57959, ChEBI:CHEBI:58441,
CC         ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66077;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-methyl-2-oxopentanoate + L-kynurenine = H2O + kynurenate +
CC         L-leucine; Xref=Rhea:RHEA:66068, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17865, ChEBI:CHEBI:57427, ChEBI:CHEBI:57959,
CC         ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66069;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-methionine = 4-methylsulfanyl-2-oxobutanoate +
CC         glycine; Xref=Rhea:RHEA:22884, ChEBI:CHEBI:16723, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:57844; EC=2.6.1.73;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-2-aminoadipate = 2-oxoadipate + glycine;
CC         Xref=Rhea:RHEA:69112, ChEBI:CHEBI:36655, ChEBI:CHEBI:57305,
CC         ChEBI:CHEBI:57499, ChEBI:CHEBI:58672;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69113;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-tyrosine = 3-(4-hydroxyphenyl)pyruvate +
CC         glycine; Xref=Rhea:RHEA:69116, ChEBI:CHEBI:36242, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:58315;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-phenylalanine = 3-phenylpyruvate + glycine;
CC         Xref=Rhea:RHEA:69120, ChEBI:CHEBI:18005, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:58095;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-tryptophan = glycine + indole-3-pyruvate;
CC         Xref=Rhea:RHEA:69124, ChEBI:CHEBI:17640, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:57912;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-leucine = 4-methyl-2-oxopentanoate + glycine;
CC         Xref=Rhea:RHEA:69128, ChEBI:CHEBI:17865, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:57427;
CC         Evidence={ECO:0000250|UniProtKB:Q8N5Z0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxobutanoate + L-kynurenine = (2S)-2-aminobutanoate + H2O +
CC         kynurenate; Xref=Rhea:RHEA:66044, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16763, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454,
CC         ChEBI:CHEBI:74359; Evidence={ECO:0000269|PubMed:7493966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66045;
CC         Evidence={ECO:0000305|PubMed:7493966};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoadipate + L-kynurenine = H2O + kynurenate + L-2-
CC         aminoadipate; Xref=Rhea:RHEA:70047, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57499, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454,
CC         ChEBI:CHEBI:58672; Evidence={ECO:0000269|PubMed:7493966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70048;
CC         Evidence={ECO:0000305|PubMed:7493966};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoadipate + L-kynurenine = 4-(2-aminophenyl)-2,4-
CC         dioxobutanoate + L-2-aminoadipate; Xref=Rhea:RHEA:70051,
CC         ChEBI:CHEBI:57499, ChEBI:CHEBI:57959, ChEBI:CHEBI:58147,
CC         ChEBI:CHEBI:58672; Evidence={ECO:0000269|PubMed:7493966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70052;
CC         Evidence={ECO:0000305|PubMed:7493966};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.33 mM for L-kynurenine {ECO:0000269|PubMed:7493966};
CC         KM=1.36 mM for 3-hydroxy-L-kynurenine {ECO:0000269|PubMed:7493966};
CC         KM=45.5 uM for 2-oxoglutarate {ECO:0000269|PubMed:7493966};
CC         KM=5.6 mM for L-glutamate {ECO:0000269|PubMed:7493966};
CC         Vmax=135 nmol/min/mg enzyme toward L-kynurenine
CC         {ECO:0000269|PubMed:7493966};
CC         Vmax=166 nmol/min/mg enzyme toward 3-hydroxy-L-kynurenine
CC         {ECO:0000269|PubMed:7493966};
CC         Vmax=910 nmol/min/mg enzyme toward 3-hydroxy-L-kynurenine
CC         {ECO:0000269|PubMed:7493966};
CC   -!- PATHWAY: Amino-acid degradation; L-lysine degradation via saccharopine
CC       pathway; glutaryl-CoA from L-lysine: step 4/6.
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z50144; CAA90507.1; -; mRNA.
DR   EMBL; BC078864; AAH78864.1; -; mRNA.
DR   RefSeq; NP_058889.1; NM_017193.1.
DR   AlphaFoldDB; Q64602; -.
DR   SMR; Q64602; -.
DR   STRING; 10116.ENSRNOP00000015974; -.
DR   BindingDB; Q64602; -.
DR   ChEMBL; CHEMBL2662; -.
DR   iPTMnet; Q64602; -.
DR   PhosphoSitePlus; Q64602; -.
DR   PaxDb; 10116-ENSRNOP00000015974; -.
DR   Ensembl; ENSRNOT00055020837; ENSRNOP00055016815; ENSRNOG00055012248.
DR   Ensembl; ENSRNOT00060011207; ENSRNOP00060008370; ENSRNOG00060006840.
DR   Ensembl; ENSRNOT00065006411; ENSRNOP00065004513; ENSRNOG00065004394.
DR   GeneID; 29416; -.
DR   KEGG; rno:29416; -.
DR   UCSC; RGD:2948; rat.
DR   AGR; RGD:2948; -.
DR   CTD; 51166; -.
DR   RGD; 2948; Aadat.
DR   VEuPathDB; HostDB:ENSRNOG00000011861; -.
DR   eggNOG; KOG0634; Eukaryota.
DR   InParanoid; Q64602; -.
DR   OrthoDB; 5486605at2759; -.
DR   PhylomeDB; Q64602; -.
DR   TreeFam; TF328598; -.
DR   BioCyc; MetaCyc:MONOMER-12251; -.
DR   BRENDA; 2.6.1.39; 5301.
DR   BRENDA; 2.6.1.7; 5301.
DR   Reactome; R-RNO-71064; Lysine catabolism.
DR   Reactome; R-RNO-71240; Tryptophan catabolism.
DR   SABIO-RK; Q64602; -.
DR   UniPathway; UPA00868; UER00838.
DR   PRO; PR:Q64602; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000011861; Expressed in kidney and 16 other cell types or tissues.
DR   ExpressionAtlas; Q64602; baseline and differential.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0047536; F:2-aminoadipate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0047958; F:glycine:2-oxoglutarate aminotransferase activity; ISS:UniProtKB.
DR   GO; GO:0047315; F:kynurenine-glyoxylate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0016212; F:kynurenine-oxoglutarate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0050094; F:methionine-glyoxylate transaminase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0008483; F:transaminase activity; TAS:RGD.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; ISS:UniProtKB.
DR   GO; GO:1901605; P:alpha-amino acid metabolic process; IBA:GO_Central.
DR   GO; GO:0009058; P:biosynthetic process; IEA:InterPro.
DR   GO; GO:0006536; P:glutamate metabolic process; ISS:UniProtKB.
DR   GO; GO:0070189; P:kynurenine metabolic process; ISS:UniProtKB.
DR   GO; GO:0033512; P:L-lysine catabolic process to acetyl-CoA via saccharopine; IEA:UniProtKB-UniPathway.
DR   CDD; cd00609; AAT_like; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR050859; Class-I_PLP-Dep_Aminotransf.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   PANTHER; PTHR42790; AMINOTRANSFERASE; 1.
DR   PANTHER; PTHR42790:SF3; KYNURENINE_ALPHA-AMINOADIPATE AMINOTRANSFERASE, MITOCHONDRIAL; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Aminotransferase; Direct protein sequencing; Mitochondrion;
KW   Phosphoprotein; Pyridoxal phosphate; Reference proteome; Transferase;
KW   Transit peptide.
FT   TRANSIT         1..29
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           30..425
FT                   /note="Kynurenine/alpha-aminoadipate aminotransferase,
FT                   mitochondrial"
FT                   /id="PRO_0000020604"
FT   REGION          179..208
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        194..208
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         20
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         74
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         142
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         202
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         399
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         172
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         179
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         263
FT                   /note="N6-(pyridoxal phosphate)lysine; alternate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         263
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         263
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         339
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         339
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         351
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         367
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         367
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
FT   MOD_RES         422
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVM8"
SQ   SEQUENCE   425 AA;  47784 MW;  DDC33DBF21163564 CRC64;
     MNYSRFLTAT SLARKTSPIR ATVEIMSRAP KDIISLAPGS PNPKVFPFKS AVFTVENGST
     IRFEGEMFQR ALQYSSSYGI PELLSWLKQL QIKLHNPPTV NYSPNEGQMD LCITSGCQDG
     LCKVFEMLIN PGDTVLVNEP LYSGALFAMK PLGCNFISVP SDDCGIIPEG LKKVLSQWKP
     EDSKDPTKRT PKFLYTIPNG NNPTGNSLTG DRKKEIYELA RKYDFLIIED DPYYFLQFTK
     PWEPTFLSMD VDGRVIRADS LSKVISSGLR VGFITGPKSL IQRIVLHTQI SSLHPCTLSQ
     LMISELLYQW GEEGFLAHVD RAIDFYKNQR DFILAAADKW LRGLAEWHVP KAGMFLWIKV
     NGISDAKKLI EEKAIEREIL LVPGNSFFVD NSAPSSFFRA SFSQVTPAQM DLVFQRLAQL
     IKDVS
//
